<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2026-12-24-27</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-5123</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Влияние ревматологического сопровождения на послеоперационный прогноз при эндопротезировании тазобедренного сустава у пациентов с ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>The effect of rheumatological support on the postoperative prognosis after hip arthroplasty in patients with rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5289-2691</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хасанов</surname><given-names>Э. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Khasanov</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хасанов Эльдар Равилевич, аспирант кафедры травматологии, ортопедии и хирургии экстремальных состояний.</p></bio><bio xml:lang="en"><p>Khasanov Eldar R., postgraduate student of Dept of Traumatology, Orthopedics, and Emergency Surgery</p></bio><email xlink:type="simple">haselik1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4910-8835</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахтямов</surname><given-names>И. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Akhtiamov</surname><given-names>I. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ахтямов Ильдар Фуатович, д. м. н., проф., зав. кафедрой травматологии, ортопедии и хирургии экстремальных состояний.</p></bio><bio xml:lang="en"><p>Akhtiamov Ildar F., Dr Med Sci (habil.), professor, of Dept of Traumatology, Orthopedics, and Emergency Surgery.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2026</year></pub-date><volume>0</volume><issue>12</issue><issue-title>Ревматология в общей врачебной практике (1)</issue-title><fpage>24</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хасанов Э.Р., Ахтямов И.Ф., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Хасанов Э.Р., Ахтямов И.Ф.</copyright-holder><copyright-holder xml:lang="en">Khasanov E.R., Akhtiamov I.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/5123">https://www.med-alphabet.com/jour/article/view/5123</self-uri><abstract><p>Цель исследования. Изучить влияние систематического ревматологического наблюдения на исходы тотального эндопротезирования тазобедренного сустава (ЭТБС) у пациентов с ревматоидным артритом (РА) на основе ретроспективного анализа. Материалы и методы. В исследование включены данные 194 пациентов с РА, перенесших ЭТБС. Основная группа (n=143) получала регулярное ревматологическое сопровождение, тогда как группа сравнения (n=51) не наблюдалась систематически. Оценивались степень костной деструкции, интраоперационная кровопотеря, особенности оперативных вмешательств и функциональные результаты. Результаты. Регулярное ревматологическое наблюдение было связано с достоверно более низкой частотой остеопороза (47,6 % против 70,6 %; p=0,0054), меньшей кровопотерей (320±102 мл против 375±110 мл) и улучшением клинико-функциональных показателей (снижение DAS 28 с 4,6 до 2,6; p&lt;0,01, улучшение short-HAQ и шкалы Харриса). У пациентов без ревматологического контроля чаще требовались костные реконструкции и дополнительные методы фиксации. Максимальная кровопотеря отмечалась у пациентов, получавших глюкокортикостероиды (до 450 мл; p&lt;0,0001). Выводы. Системное ревматологическое сопровождение пациентов с РА при ЭТБС способствует снижению интраоперационных и послеоперационных рисков, улучшает анатомо-функциональные результаты и должно рассматриваться как неотъемлемая часть комплексного подхода к лечению.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To assess the impact of systematic rheumatologic supervision on the outcomes of total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) through retrospective analysis. Materials and methods. This study analyzed data from 194 RA patients who underwent primary THA. The main group (n=143) received regular rheumatologic care, while the comparison group (n=51) did not. Outcomes assessed included the presence of osteoporosis, acetabular defects, intraoperative blood loss, surgical techniques, and functional results. Results. Patients under regular rheumatologic care had a lower incidence of osteoporosis (47.6 % vs. 70.6 %; p=0.0054), reduced blood loss (320±102 ml vs. 375±110 ml), and better clinical outcomes (DAS 28 improved from 4.6 to 2.6; p&lt;0.01; short-HAQ and Harris Hip Scores also improved). Those without rheumatologic supervision required more frequent bone grafting and screw fixation. The highest blood loss was observed in patients   receiving glucocorticoids (up to 450 ml; p&lt;0.0001). Conclusion. Systematic rheumatologic management before, during, and after THA significantly reduces surgical risks and improves both anatomical and clinical outcomes in RA patients. It should be considered an essential component of comprehensive care in joint replacement surgery.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эндопротезирование тазобедренного сустава</kwd><kwd>ревматоидный артрит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hip arthroplasty</kwd><kwd>rhematoid arthritis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S. C., Park H. C., Lee K. H. Perioperative Considerations for Hip Arthroplasty in Pa tients with Rheumatoid Arthritis. Hip &amp; Pelvis. 2024; 36 (4): 250–259. DOI: 10.5371/hp.2024.36.4.250</mixed-citation><mixed-citation xml:lang="en">Kim S. C., Park H. C., Lee K. H. Perioperative Considerations for Hip Arthroplasty in Pa tients with Rheumatoid Arthritis. Hip &amp; Pelvis. 2024; 36 (4): 250–259. DOI: 10.5371/hp.2024.36.4.250</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Liu P., Qiao Y. J., Lou J. P. et al. Cementless total hip arthroplasty for treatment of ace tabular protrusion secondary to rheumatoid arthritis. Journal of orthopedics surgery &amp; research. 2023; 18 (1): 282. DOI: 10.1186/s13018-023-03764-y</mixed-citation><mixed-citation xml:lang="en">Liu P., Qiao Y. J., Lou J. P. et al. Cementless total hip arthroplasty for treatment of ace tabular protrusion secondary to rheumatoid arthritis. Journal of orthopedics surgery &amp; research. 2023; 18 (1): 282. DOI: 10.1186/s13018-023-03764-y</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">George M. D., Baker J. F., Winthrop K. et al. Risk of Biologics and Glucocorticoids in Patients with Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study. Annals if internal medicine. 2019; 170 (12): 825–836. DOI: 10.7326/M18-2217</mixed-citation><mixed-citation xml:lang="en">George M. D., Baker J. F., Winthrop K. et al. Risk of Biologics and Glucocorticoids in Patients with Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study. Annals if internal medicine. 2019; 170 (12): 825–836. DOI: 10.7326/M18-2217</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Храмов А. Э., Макаров М. А., Макаров С. А. и соавт. Местные осложнения эндопротезирования тазобедренного и коленного суставов у пациентов с ревматоидным артритом и остеоартритом. Научно-практическая ревматология. 2017; 55 (5): 549–554. DOI: 10.14412/1995-4484-2017-549-554</mixed-citation><mixed-citation xml:lang="en">Khramov A. E., Makarov M. A., Makarov S. A. et al. Local complications of hip and knee joint arthtroplasty in patients with rheumatoid arthritis and osteoarthritis. Sci entific and Practical Rheumatology. 2017; 55 (5): 549–554. (In Russ.). DOI: 10.14412/1995-4484-2017-549-554</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hu L. J., Ji B., Fan H. X. Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis. European review for medical and pharmacological sciences. 2021; 25 (22): 7005–7013. DOI: 10.26355/eurrev_202111_27249</mixed-citation><mixed-citation xml:lang="en">Hu L. J., Ji B., Fan H. X. Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis. European review for medical and pharmacological sciences. 2021; 25 (22): 7005–7013. DOI: 10.26355/eurrev_202111_27249</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sakthivelnathan V., Goel A., Serbin P. A. et al. Cost and Complications in Rheumatoid Arthritis Patients Undergoing Primary Hip Arthroplasty: A National Inpatient Sample-Based Study. Cureus. 2022; 14 (10): e30483. DOI: 10.7759/cureus.30483</mixed-citation><mixed-citation xml:lang="en">Sakthivelnathan V., Goel A., Serbin P. A. et al. Cost and Complications in Rheumatoid Arthritis Patients Undergoing Primary Hip Arthroplasty: A National Inpatient Sample-Based Study. Cureus. 2022; 14 (10): e30483. DOI: 10.7759/cureus.30483</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е. Л. Фармакотерапия ревматоидного артрита: российские и международные рекомендации. Научно-практическая ревматология. 2016; 54 (5): 557–571. DOI: 10.14412/1995-4484-2016-557-571</mixed-citation><mixed-citation xml:lang="en">Nasonov E. L. Pharmacotherapy of Rheumatoid Arthritis: Russian and International Re commendations. Scientific and Practical Rheumatology. 2016; 54 (5): 557–571. (In Russ.). DOI: 10.14412/1995-4484-2016-557-571</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е. Л. Метотрексат при ревматоидном артрите – 2015: новые факты и идеи. Научно-практическая ревматология. 2015; 53 (5s): 64–76. DOI: 10.14412/1995-4484-2015-64-76</mixed-citation><mixed-citation xml:lang="en">Nasonov E. L. Methotrexate in Rheumatoid Arthritis – 2015: New Facts and Ideas. Scientific and Practical Rheumatology. (In Russ.). 2015; 53 (5s): 64–76. DOI: 10.14412/1995-4484-2015-64-76</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5 (10): e594–e610. DOI: 10.1016/S2665-9913(23)00211-4</mixed-citation><mixed-citation xml:lang="en">GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5 (10): e594–e610. DOI: 10.1016/S2665-9913(23)00211-4</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
